glp-1 patent expiration Patents and regulatory exclusivities on receptor agonists Could GLP-1 Drugs Shrink Sugar

Your provider will adjust every four weeks until you reach your optimal dose, semaglutide around 2.4 mg, tirzepatide around 5, 10, or 15 mg

In response, many consumers turned to more accessible and less expensive compounded versions

Breastfeeding should not hurt

Our attorneys will guide you through the process and work to determine the best course of legal action

FDA is requesting that the risk be removed from the warnings and precautions section of labeling for the GLP-1 obesity drugs Eli Lilly and Co.s Zepbound (tirzepatide) and Novo Nordisk A/S Saxenda (liraglutide) and Wegovy (semaglutide)

June 1, 2026: More Than 125 Lawsuits Join GLP-1 MDL as Eli Lilly Asks for Dismissal of Plaintiffs Experts With the GLP-1 MDL reaching 3,763 total cases as of June 1, Eli Lilly, the manufacturer of Ozempic, has requested that the judge dismiss the plaintiffs experts